药物洗脱球囊(Drug-coated balloons)具有潜在的均匀一致的药物释放到血管壁,可以立即释放药物而不需要聚合物。可以单 …www.ynjr.net|基于2个网页 2. 药物涂层球囊 应用药物涂层球囊(Drug-coated balloons)和药物洗脱支架(Drug-eluting stent),可拟制局部炎症反应和平滑肌增殖,预防 …www.365heart.com|基于1 个网页...
14.将来新型药物球囊的研发,可能不止有紫杉醇,但首先要循证医学证明其有效性,其次考究其安全性和效率。目前的证据未提示紫杉醇可以明显增加死亡率。 Source:Drug-Coated Balloons for Coronary Artery Disease Third Report of the International DCB Consensus Group...
An alternative approach using drug-coated balloons (DCBs) is gaining growing interest, having the potential of delivering therapy directly to vulnerable plaques, avoiding the need for permanent metallic implants, and potentially allowing for better long-term medical treatment. Despite limited evidence, ...
参考文献: 1. Schneider PA, Laird JR, Tepe G, et al. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial. Circ Cardiova...
The PCR-EAPCI Textbook Drug-coated balloons (DCB) are gaining attraction worldwide for the treatment of peripheral and coronary lesions. The basic prerequisite for this therapy is the best possible lesion preparation. DCBs cannot replace drug-eluting stents, but will play an important role in the...
(ECM)48,49,50,51,52,53,54. Since arterial ultrastructure modulates drug delivery from coated balloons, an attempt is made to investigate the DCB delivery in a patient-specific atherosclerotic artery, which is driven by the two-phase binding of drug (specific and non-specific) by applying a ...
Drug-coated balloons, which are not currently approved in the United States, can deliver drugs that inhibit blockages from reforming, "without leaving additional layers of metal behind," he added. Such devices are already available in Europe and Japan. ...
2 products Compare PDFEmail We value keeping the Device Guide up to date. If you want to add or update your company’s device listings, please let us know! Contact Us
Early exposure to the use of drug-coated balloons (DCBs) for percutaneous coronary intervention (PCI) “opened my eyes to a whole new world of angioplasty without putting stents in,” Simon Eccleshall (Norwich, UK) tells Cardiovascular News, detailing how the technology has come to play an imp...
Engineered to deliver stent-like patency and restenosis prevention with long-term release of two synergistic drugs.